These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19925383)

  • 1. Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients.
    Chen B; Zhang W; Fang J; Jin Z; Li J; Yu Z; Cai W
    Xenobiotica; 2009 Dec; 39(12):931-8. PubMed ID: 19925383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.
    Qiu XY; Jiao Z; Zhang M; Zhong LJ; Liang HQ; Ma CL; Zhang L; Zhong MK
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1069-84. PubMed ID: 18636247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y; Wang C; Li J; Wang X; Zhu G; Chen X; Bi H; Huang M
    Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.
    Hu YF; Qiu W; Liu ZQ; Zhu LJ; Liu ZQ; Tu JH; Wang D; Li Z; He J; Zhong GP; Zhou G; Zhou HH
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1093-8. PubMed ID: 17042920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.
    Xu P; Jiang ZP; Zhang BK; Tu JY; Li HD
    Pharmacology; 2008; 82(3):221-7. PubMed ID: 18810246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients.
    Qiu F; He XJ; Sun YX; Li-Ling J; Zhao LM
    Pharmacol Rep; 2011; 63(3):815-25. PubMed ID: 21857093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.
    Meng XG; Guo CX; Feng GQ; Zhao YC; Zhou BT; Han JL; Chen X; Shi Y; Shi HY; Yin JY; Peng XD; Pei Q; Zhang W; Wang G; He M; Liu M; Yang JK; Zhou HH
    Acta Pharmacol Sin; 2012 Dec; 33(12):1563-70. PubMed ID: 23085740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
    Zhang Y; Li JL; Fu Q; Wang XD; Liu LS; Wang CX; Xie W; Chen ZJ; Shu WY; Huang M
    Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.
    Chen B; Zhang W; Gu Z; Li J; Zhang Y; Cai W
    Eur J Clin Pharmacol; 2011 Jun; 67(6):601-12. PubMed ID: 21161198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
    Wang YX; Li JL; Wang XD; Zhang Y; Wang CX; Huang M
    Acta Pharmacol Sin; 2015 Jul; 36(7):855-62. PubMed ID: 25891084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects.
    Choi JH; Lee YJ; Jang SB; Lee JE; Kim KH; Park K
    Br J Clin Pharmacol; 2007 Aug; 64(2):185-91. PubMed ID: 17391324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.
    Rong G; Jing L; Deng-Qing L; Hong-Shan Z; Shai-Hong Z; Xin-Min N
    Transplant Proc; 2010 Nov; 42(9):3455-8. PubMed ID: 21094796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients.
    Wu P; Ni X; Wang M; Xu X; Luo G; Jiang Y
    Ann Transplant; 2011; 16(1):54-60. PubMed ID: 21436775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients.
    Lee J; Huang H; Chen Y; Lu X
    Biopharm Drug Dispos; 2014 Apr; 35(3):164-72. PubMed ID: 24285256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.
    García M; Macías RM; Cubero JJ; Benítez J; Caravaca F; Gervasini G
    Eur J Clin Pharmacol; 2013 Mar; 69(3):385-93. PubMed ID: 22886152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients.
    Miao LY; Huang CR; Hou JQ; Qian MY
    Biopharm Drug Dispos; 2008 Jan; 29(1):1-5. PubMed ID: 17941052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
    Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
    J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
    Crettol S; Venetz JP; Fontana M; Aubert JD; Pascual M; Eap CB
    Ther Drug Monit; 2008 Dec; 30(6):689-99. PubMed ID: 18978522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH; Yoon YD; Park JY; Song EJ; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation.
    Vannaprasaht S; Reungjui S; Supanya D; Sirivongs D; Pongskul C; Avihingsanon Y; Tassaneeyakul W
    Clin Ther; 2013 Nov; 35(11):1762-9. PubMed ID: 24120259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.